Loading tape…Loading tape…
PTGX
PTGX
Indices, commodities, movers, heatmap, and top stories. No login required.
Indices, commodities, movers, heatmap, and top stories. No login required.
PTGX
PTGX NASDAQ
Analyzing Protagonist Therapeutics (NASDAQ:PTGX) and Sarepta Therapeutics (NASDAQ:SRPT)
Head to Head Review: Genelux (NASDAQ:GNLX) versus Protagonist Therapeutics (NASDAQ:PTGX)
Protagonist Therapeutics (PTGX) Upgraded to Strong Buy: Here's What You Should Know
Protagonist Therapeutics (NASDAQ:PTGX) & MiMedx Group (NASDAQ:MDXG) Head-To-Head Review
Protagonist Therapeutics (NASDAQ:PTGX) CEO Sells $9,289,446.64 in Stock
Protagonist Therapeutics (NASDAQ:PTGX) CEO Sells $7,902,361.38 in Stock
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.